October 14th 2026, 2:58 PM
Injective Enters Wall Street with Proposed INJC Staking ETF
Key Summary
Injective, a Layer 1 blockchain for finance and tokenization, is moving closer to listing its native token INJ on Wall Street with a proposed staking ETF, INJC, which would offer investors spot exposure to INJ without a crypto wallet. The fund, backed by Canary Capital, aims to stake 90% of its holdings for extra yield, and is pending approval with the SEC.
Please see our real time news feed on our Home Page
What INJC Actually Is
INJC would hold INJ tokens directly, giving investors spot exposure to the asset's price. On top of that, the fund's structure targets staking approximately 90% of its holdings.The Bigger Picture for Staked Crypto ETFs
Staking inside an ETF adds a yield component, which makes it look a bit more like an income investment and a bit less like a pure price bet. Staked tokens can be harder to move quickly, so a fund that stakes most of its holdings has to manage redemptions carefully. Keeping a slice unstaked is one way to handle that.Regulatory Timelines and Ecosystem Impact
If approved, INJC could open the token to investors who would never set up a crypto exchange account. Three separate INJ applications suggest issuers see demand. Regulatory timelines can slip, and the Injective CEO's pre-2027 view remains a projection, not a decision. Staking also carries its own technical and liquidity considerations that a traditional ETF investor may not be used to thinking about.What to Watch Next
Further amendments to Canary's S-1, any movement on the 21Shares and REX-Osprey proposals, and whether the SEC signals comfort with staking inside an exchange-traded wrapper will be key. On the ecosystem side, how Sprout, RunUp, and other Trench Treasury recipients develop will show whether Injective's on-chain activity can keep pace with its Wall Street ambitions.#Crypto#US#ETF#SEC